Efficacy and safety of pegylated liposomal doxorubicin in patients with advanced breast cancer

Trial Profile

Efficacy and safety of pegylated liposomal doxorubicin in patients with advanced breast cancer

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 13 Feb 2015

At a glance

  • Drugs Doxorubicin liposomal (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top